Global Rofecoxib Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Rofecoxib market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.Rofecoxib was available by prescription in both tablet-form and as an oral suspension.
The Global Info Research report includes an overview of the development of the Rofecoxib industry chain, the market status of Osteoarthritis (Oral Suspension., Tablet-Form), Rheumatoid Arthritis (Oral Suspension., Tablet-Form), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Rofecoxib.
Regionally, the report analyzes the Rofecoxib markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Rofecoxib market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Rofecoxib market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Rofecoxib industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Oral Suspension., Tablet-Form).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Rofecoxib market.
Regional Analysis: The report involves examining the Rofecoxib market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Rofecoxib market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Rofecoxib:
Company Analysis: Report covers individual Rofecoxib manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Rofecoxib This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Osteoarthritis, Rheumatoid Arthritis).
Technology Analysis: Report covers specific technologies relevant to Rofecoxib. It assesses the current state, advancements, and potential future developments in Rofecoxib areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Rofecoxib market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Rofecoxib market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Rofecoxib product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rofecoxib, with price, sales, revenue and global market share of Rofecoxib from 2019 to 2024.
Chapter 3, the Rofecoxib competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rofecoxib breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Rofecoxib market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rofecoxib.
Chapter 14 and 15, to describe Rofecoxib sales channel, distributors, customers, research findings and conclusion.
Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.Rofecoxib was available by prescription in both tablet-form and as an oral suspension.
The Global Info Research report includes an overview of the development of the Rofecoxib industry chain, the market status of Osteoarthritis (Oral Suspension., Tablet-Form), Rheumatoid Arthritis (Oral Suspension., Tablet-Form), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Rofecoxib.
Regionally, the report analyzes the Rofecoxib markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Rofecoxib market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Rofecoxib market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Rofecoxib industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Oral Suspension., Tablet-Form).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Rofecoxib market.
Regional Analysis: The report involves examining the Rofecoxib market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Rofecoxib market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Rofecoxib:
Company Analysis: Report covers individual Rofecoxib manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Rofecoxib This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Osteoarthritis, Rheumatoid Arthritis).
Technology Analysis: Report covers specific technologies relevant to Rofecoxib. It assesses the current state, advancements, and potential future developments in Rofecoxib areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Rofecoxib market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Rofecoxib market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Oral Suspension.
- Tablet-Form
- Osteoarthritis
- Rheumatoid Arthritis
- Juvenile Rheumatoid Arthritis
- Acute Pain Conditions
- Migraine
- Dysmenorrhea
- Merck
- Chengdu Meinkai Chemical Co. LTD
- Wuhan Xinxin Jiali Biotechnology Co. LTD
- Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
- Pfizer
- Tremeau
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Rofecoxib product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Rofecoxib, with price, sales, revenue and global market share of Rofecoxib from 2019 to 2024.
Chapter 3, the Rofecoxib competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rofecoxib breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Rofecoxib market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Rofecoxib.
Chapter 14 and 15, to describe Rofecoxib sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Rofecoxib
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rofecoxib Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Oral Suspension.
1.3.3 Tablet-Form
1.4 Market Analysis by Application
1.4.1 Overview: Global Rofecoxib Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Osteoarthritis
1.4.3 Rheumatoid Arthritis
1.4.4 Juvenile Rheumatoid Arthritis
1.4.5 Acute Pain Conditions
1.4.6 Migraine
1.4.7 Dysmenorrhea
1.5 Global Rofecoxib Market Size & Forecast
1.5.1 Global Rofecoxib Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Rofecoxib Sales Quantity (2019-2030)
1.5.3 Global Rofecoxib Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Rofecoxib Product and Services
2.1.4 Merck Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 Chengdu Meinkai Chemical Co. LTD
2.2.1 Chengdu Meinkai Chemical Co. LTD Details
2.2.2 Chengdu Meinkai Chemical Co. LTD Major Business
2.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product and Services
2.2.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Chengdu Meinkai Chemical Co. LTD Recent Developments/Updates
2.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
2.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Details
2.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Major Business
2.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product and Services
2.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments/Updates
2.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
2.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Details
2.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Major Business
2.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product and Services
2.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments/Updates
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Rofecoxib Product and Services
2.5.4 Pfizer Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pfizer Recent Developments/Updates
2.6 Tremeau
2.6.1 Tremeau Details
2.6.2 Tremeau Major Business
2.6.3 Tremeau Rofecoxib Product and Services
2.6.4 Tremeau Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Tremeau Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ROFECOXIB BY MANUFACTURER
3.1 Global Rofecoxib Sales Quantity by Manufacturer (2019-2024)
3.2 Global Rofecoxib Revenue by Manufacturer (2019-2024)
3.3 Global Rofecoxib Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Rofecoxib by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Rofecoxib Manufacturer Market Share in 2023
3.4.2 Top 6 Rofecoxib Manufacturer Market Share in 2023
3.5 Rofecoxib Market: Overall Company Footprint Analysis
3.5.1 Rofecoxib Market: Region Footprint
3.5.2 Rofecoxib Market: Company Product Type Footprint
3.5.3 Rofecoxib Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Rofecoxib Market Size by Region
4.1.1 Global Rofecoxib Sales Quantity by Region (2019-2030)
4.1.2 Global Rofecoxib Consumption Value by Region (2019-2030)
4.1.3 Global Rofecoxib Average Price by Region (2019-2030)
4.2 North America Rofecoxib Consumption Value (2019-2030)
4.3 Europe Rofecoxib Consumption Value (2019-2030)
4.4 Asia-Pacific Rofecoxib Consumption Value (2019-2030)
4.5 South America Rofecoxib Consumption Value (2019-2030)
4.6 Middle East and Africa Rofecoxib Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Rofecoxib Sales Quantity by Type (2019-2030)
5.2 Global Rofecoxib Consumption Value by Type (2019-2030)
5.3 Global Rofecoxib Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Rofecoxib Sales Quantity by Application (2019-2030)
6.2 Global Rofecoxib Consumption Value by Application (2019-2030)
6.3 Global Rofecoxib Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Rofecoxib Sales Quantity by Type (2019-2030)
7.2 North America Rofecoxib Sales Quantity by Application (2019-2030)
7.3 North America Rofecoxib Market Size by Country
7.3.1 North America Rofecoxib Sales Quantity by Country (2019-2030)
7.3.2 North America Rofecoxib Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Rofecoxib Sales Quantity by Type (2019-2030)
8.2 Europe Rofecoxib Sales Quantity by Application (2019-2030)
8.3 Europe Rofecoxib Market Size by Country
8.3.1 Europe Rofecoxib Sales Quantity by Country (2019-2030)
8.3.2 Europe Rofecoxib Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Rofecoxib Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Rofecoxib Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Rofecoxib Market Size by Region
9.3.1 Asia-Pacific Rofecoxib Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Rofecoxib Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Rofecoxib Sales Quantity by Type (2019-2030)
10.2 South America Rofecoxib Sales Quantity by Application (2019-2030)
10.3 South America Rofecoxib Market Size by Country
10.3.1 South America Rofecoxib Sales Quantity by Country (2019-2030)
10.3.2 South America Rofecoxib Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Rofecoxib Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Rofecoxib Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Rofecoxib Market Size by Country
11.3.1 Middle East & Africa Rofecoxib Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Rofecoxib Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Rofecoxib Market Drivers
12.2 Rofecoxib Market Restraints
12.3 Rofecoxib Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Rofecoxib and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rofecoxib
13.3 Rofecoxib Production Process
13.4 Rofecoxib Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rofecoxib Typical Distributors
14.3 Rofecoxib Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Rofecoxib
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rofecoxib Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Oral Suspension.
1.3.3 Tablet-Form
1.4 Market Analysis by Application
1.4.1 Overview: Global Rofecoxib Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Osteoarthritis
1.4.3 Rheumatoid Arthritis
1.4.4 Juvenile Rheumatoid Arthritis
1.4.5 Acute Pain Conditions
1.4.6 Migraine
1.4.7 Dysmenorrhea
1.5 Global Rofecoxib Market Size & Forecast
1.5.1 Global Rofecoxib Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Rofecoxib Sales Quantity (2019-2030)
1.5.3 Global Rofecoxib Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Rofecoxib Product and Services
2.1.4 Merck Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 Chengdu Meinkai Chemical Co. LTD
2.2.1 Chengdu Meinkai Chemical Co. LTD Details
2.2.2 Chengdu Meinkai Chemical Co. LTD Major Business
2.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product and Services
2.2.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Chengdu Meinkai Chemical Co. LTD Recent Developments/Updates
2.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
2.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Details
2.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Major Business
2.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product and Services
2.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments/Updates
2.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
2.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Details
2.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Major Business
2.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product and Services
2.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments/Updates
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Rofecoxib Product and Services
2.5.4 Pfizer Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Pfizer Recent Developments/Updates
2.6 Tremeau
2.6.1 Tremeau Details
2.6.2 Tremeau Major Business
2.6.3 Tremeau Rofecoxib Product and Services
2.6.4 Tremeau Rofecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Tremeau Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ROFECOXIB BY MANUFACTURER
3.1 Global Rofecoxib Sales Quantity by Manufacturer (2019-2024)
3.2 Global Rofecoxib Revenue by Manufacturer (2019-2024)
3.3 Global Rofecoxib Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Rofecoxib by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Rofecoxib Manufacturer Market Share in 2023
3.4.2 Top 6 Rofecoxib Manufacturer Market Share in 2023
3.5 Rofecoxib Market: Overall Company Footprint Analysis
3.5.1 Rofecoxib Market: Region Footprint
3.5.2 Rofecoxib Market: Company Product Type Footprint
3.5.3 Rofecoxib Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Rofecoxib Market Size by Region
4.1.1 Global Rofecoxib Sales Quantity by Region (2019-2030)
4.1.2 Global Rofecoxib Consumption Value by Region (2019-2030)
4.1.3 Global Rofecoxib Average Price by Region (2019-2030)
4.2 North America Rofecoxib Consumption Value (2019-2030)
4.3 Europe Rofecoxib Consumption Value (2019-2030)
4.4 Asia-Pacific Rofecoxib Consumption Value (2019-2030)
4.5 South America Rofecoxib Consumption Value (2019-2030)
4.6 Middle East and Africa Rofecoxib Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Rofecoxib Sales Quantity by Type (2019-2030)
5.2 Global Rofecoxib Consumption Value by Type (2019-2030)
5.3 Global Rofecoxib Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Rofecoxib Sales Quantity by Application (2019-2030)
6.2 Global Rofecoxib Consumption Value by Application (2019-2030)
6.3 Global Rofecoxib Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Rofecoxib Sales Quantity by Type (2019-2030)
7.2 North America Rofecoxib Sales Quantity by Application (2019-2030)
7.3 North America Rofecoxib Market Size by Country
7.3.1 North America Rofecoxib Sales Quantity by Country (2019-2030)
7.3.2 North America Rofecoxib Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Rofecoxib Sales Quantity by Type (2019-2030)
8.2 Europe Rofecoxib Sales Quantity by Application (2019-2030)
8.3 Europe Rofecoxib Market Size by Country
8.3.1 Europe Rofecoxib Sales Quantity by Country (2019-2030)
8.3.2 Europe Rofecoxib Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Rofecoxib Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Rofecoxib Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Rofecoxib Market Size by Region
9.3.1 Asia-Pacific Rofecoxib Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Rofecoxib Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Rofecoxib Sales Quantity by Type (2019-2030)
10.2 South America Rofecoxib Sales Quantity by Application (2019-2030)
10.3 South America Rofecoxib Market Size by Country
10.3.1 South America Rofecoxib Sales Quantity by Country (2019-2030)
10.3.2 South America Rofecoxib Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Rofecoxib Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Rofecoxib Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Rofecoxib Market Size by Country
11.3.1 Middle East & Africa Rofecoxib Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Rofecoxib Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Rofecoxib Market Drivers
12.2 Rofecoxib Market Restraints
12.3 Rofecoxib Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Rofecoxib and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rofecoxib
13.3 Rofecoxib Production Process
13.4 Rofecoxib Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rofecoxib Typical Distributors
14.3 Rofecoxib Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Rofecoxib Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Rofecoxib Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Rofecoxib Product and Services
Table 6. Merck Rofecoxib Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. Chengdu Meinkai Chemical Co. LTD Basic Information, Manufacturing Base and Competitors
Table 9. Chengdu Meinkai Chemical Co. LTD Major Business
Table 10. Chengdu Meinkai Chemical Co. LTD Rofecoxib Product and Services
Table 11. Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Chengdu Meinkai Chemical Co. LTD Recent Developments/Updates
Table 13. Wuhan Xinxin Jiali Biotechnology Co. LTD Basic Information, Manufacturing Base and Competitors
Table 14. Wuhan Xinxin Jiali Biotechnology Co. LTD Major Business
Table 15. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product and Services
Table 16. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments/Updates
Table 18. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Basic Information, Manufacturing Base and Competitors
Table 19. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Major Business
Table 20. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product and Services
Table 21. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments/Updates
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Rofecoxib Product and Services
Table 26. Pfizer Rofecoxib Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Pfizer Recent Developments/Updates
Table 28. Tremeau Basic Information, Manufacturing Base and Competitors
Table 29. Tremeau Major Business
Table 30. Tremeau Rofecoxib Product and Services
Table 31. Tremeau Rofecoxib Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Tremeau Recent Developments/Updates
Table 33. Global Rofecoxib Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 34. Global Rofecoxib Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Rofecoxib Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 36. Market Position of Manufacturers in Rofecoxib, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Rofecoxib Production Site of Key Manufacturer
Table 38. Rofecoxib Market: Company Product Type Footprint
Table 39. Rofecoxib Market: Company Product Application Footprint
Table 40. Rofecoxib New Market Entrants and Barriers to Market Entry
Table 41. Rofecoxib Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Rofecoxib Sales Quantity by Region (2019-2024) & (K Units)
Table 43. Global Rofecoxib Sales Quantity by Region (2025-2030) & (K Units)
Table 44. Global Rofecoxib Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Rofecoxib Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Rofecoxib Average Price by Region (2019-2024) & (USD/Unit)
Table 47. Global Rofecoxib Average Price by Region (2025-2030) & (USD/Unit)
Table 48. Global Rofecoxib Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Global Rofecoxib Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Global Rofecoxib Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Rofecoxib Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Rofecoxib Average Price by Type (2019-2024) & (USD/Unit)
Table 53. Global Rofecoxib Average Price by Type (2025-2030) & (USD/Unit)
Table 54. Global Rofecoxib Sales Quantity by Application (2019-2024) & (K Units)
Table 55. Global Rofecoxib Sales Quantity by Application (2025-2030) & (K Units)
Table 56. Global Rofecoxib Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Rofecoxib Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Rofecoxib Average Price by Application (2019-2024) & (USD/Unit)
Table 59. Global Rofecoxib Average Price by Application (2025-2030) & (USD/Unit)
Table 60. North America Rofecoxib Sales Quantity by Type (2019-2024) & (K Units)
Table 61. North America Rofecoxib Sales Quantity by Type (2025-2030) & (K Units)
Table 62. North America Rofecoxib Sales Quantity by Application (2019-2024) & (K Units)
Table 63. North America Rofecoxib Sales Quantity by Application (2025-2030) & (K Units)
Table 64. North America Rofecoxib Sales Quantity by Country (2019-2024) & (K Units)
Table 65. North America Rofecoxib Sales Quantity by Country (2025-2030) & (K Units)
Table 66. North America Rofecoxib Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Rofecoxib Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Rofecoxib Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Europe Rofecoxib Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Europe Rofecoxib Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Europe Rofecoxib Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Europe Rofecoxib Sales Quantity by Country (2019-2024) & (K Units)
Table 73. Europe Rofecoxib Sales Quantity by Country (2025-2030) & (K Units)
Table 74. Europe Rofecoxib Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Rofecoxib Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Rofecoxib Sales Quantity by Type (2019-2024) & (K Units)
Table 77. Asia-Pacific Rofecoxib Sales Quantity by Type (2025-2030) & (K Units)
Table 78. Asia-Pacific Rofecoxib Sales Quantity by Application (2019-2024) & (K Units)
Table 79. Asia-Pacific Rofecoxib Sales Quantity by Application (2025-2030) & (K Units)
Table 80. Asia-Pacific Rofecoxib Sales Quantity by Region (2019-2024) & (K Units)
Table 81. Asia-Pacific Rofecoxib Sales Quantity by Region (2025-2030) & (K Units)
Table 82. Asia-Pacific Rofecoxib Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Rofecoxib Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Rofecoxib Sales Quantity by Type (2019-2024) & (K Units)
Table 85. South America Rofecoxib Sales Quantity by Type (2025-2030) & (K Units)
Table 86. South America Rofecoxib Sales Quantity by Application (2019-2024) & (K Units)
Table 87. South America Rofecoxib Sales Quantity by Application (2025-2030) & (K Units)
Table 88. South America Rofecoxib Sales Quantity by Country (2019-2024) & (K Units)
Table 89. South America Rofecoxib Sales Quantity by Country (2025-2030) & (K Units)
Table 90. South America Rofecoxib Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Rofecoxib Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Rofecoxib Sales Quantity by Type (2019-2024) & (K Units)
Table 93. Middle East & Africa Rofecoxib Sales Quantity by Type (2025-2030) & (K Units)
Table 94. Middle East & Africa Rofecoxib Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Middle East & Africa Rofecoxib Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Middle East & Africa Rofecoxib Sales Quantity by Region (2019-2024) & (K Units)
Table 97. Middle East & Africa Rofecoxib Sales Quantity by Region (2025-2030) & (K Units)
Table 98. Middle East & Africa Rofecoxib Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Rofecoxib Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Rofecoxib Raw Material
Table 101. Key Manufacturers of Rofecoxib Raw Materials
Table 102. Rofecoxib Typical Distributors
Table 103. Rofecoxib Typical Customers
Table 1. Global Rofecoxib Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Rofecoxib Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Rofecoxib Product and Services
Table 6. Merck Rofecoxib Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. Chengdu Meinkai Chemical Co. LTD Basic Information, Manufacturing Base and Competitors
Table 9. Chengdu Meinkai Chemical Co. LTD Major Business
Table 10. Chengdu Meinkai Chemical Co. LTD Rofecoxib Product and Services
Table 11. Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Chengdu Meinkai Chemical Co. LTD Recent Developments/Updates
Table 13. Wuhan Xinxin Jiali Biotechnology Co. LTD Basic Information, Manufacturing Base and Competitors
Table 14. Wuhan Xinxin Jiali Biotechnology Co. LTD Major Business
Table 15. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product and Services
Table 16. Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments/Updates
Table 18. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Basic Information, Manufacturing Base and Competitors
Table 19. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Major Business
Table 20. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product and Services
Table 21. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments/Updates
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Rofecoxib Product and Services
Table 26. Pfizer Rofecoxib Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Pfizer Recent Developments/Updates
Table 28. Tremeau Basic Information, Manufacturing Base and Competitors
Table 29. Tremeau Major Business
Table 30. Tremeau Rofecoxib Product and Services
Table 31. Tremeau Rofecoxib Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Tremeau Recent Developments/Updates
Table 33. Global Rofecoxib Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 34. Global Rofecoxib Revenue by Manufacturer (2019-2024) & (USD Million)
Table 35. Global Rofecoxib Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 36. Market Position of Manufacturers in Rofecoxib, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 37. Head Office and Rofecoxib Production Site of Key Manufacturer
Table 38. Rofecoxib Market: Company Product Type Footprint
Table 39. Rofecoxib Market: Company Product Application Footprint
Table 40. Rofecoxib New Market Entrants and Barriers to Market Entry
Table 41. Rofecoxib Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Rofecoxib Sales Quantity by Region (2019-2024) & (K Units)
Table 43. Global Rofecoxib Sales Quantity by Region (2025-2030) & (K Units)
Table 44. Global Rofecoxib Consumption Value by Region (2019-2024) & (USD Million)
Table 45. Global Rofecoxib Consumption Value by Region (2025-2030) & (USD Million)
Table 46. Global Rofecoxib Average Price by Region (2019-2024) & (USD/Unit)
Table 47. Global Rofecoxib Average Price by Region (2025-2030) & (USD/Unit)
Table 48. Global Rofecoxib Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Global Rofecoxib Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Global Rofecoxib Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Global Rofecoxib Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Global Rofecoxib Average Price by Type (2019-2024) & (USD/Unit)
Table 53. Global Rofecoxib Average Price by Type (2025-2030) & (USD/Unit)
Table 54. Global Rofecoxib Sales Quantity by Application (2019-2024) & (K Units)
Table 55. Global Rofecoxib Sales Quantity by Application (2025-2030) & (K Units)
Table 56. Global Rofecoxib Consumption Value by Application (2019-2024) & (USD Million)
Table 57. Global Rofecoxib Consumption Value by Application (2025-2030) & (USD Million)
Table 58. Global Rofecoxib Average Price by Application (2019-2024) & (USD/Unit)
Table 59. Global Rofecoxib Average Price by Application (2025-2030) & (USD/Unit)
Table 60. North America Rofecoxib Sales Quantity by Type (2019-2024) & (K Units)
Table 61. North America Rofecoxib Sales Quantity by Type (2025-2030) & (K Units)
Table 62. North America Rofecoxib Sales Quantity by Application (2019-2024) & (K Units)
Table 63. North America Rofecoxib Sales Quantity by Application (2025-2030) & (K Units)
Table 64. North America Rofecoxib Sales Quantity by Country (2019-2024) & (K Units)
Table 65. North America Rofecoxib Sales Quantity by Country (2025-2030) & (K Units)
Table 66. North America Rofecoxib Consumption Value by Country (2019-2024) & (USD Million)
Table 67. North America Rofecoxib Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Europe Rofecoxib Sales Quantity by Type (2019-2024) & (K Units)
Table 69. Europe Rofecoxib Sales Quantity by Type (2025-2030) & (K Units)
Table 70. Europe Rofecoxib Sales Quantity by Application (2019-2024) & (K Units)
Table 71. Europe Rofecoxib Sales Quantity by Application (2025-2030) & (K Units)
Table 72. Europe Rofecoxib Sales Quantity by Country (2019-2024) & (K Units)
Table 73. Europe Rofecoxib Sales Quantity by Country (2025-2030) & (K Units)
Table 74. Europe Rofecoxib Consumption Value by Country (2019-2024) & (USD Million)
Table 75. Europe Rofecoxib Consumption Value by Country (2025-2030) & (USD Million)
Table 76. Asia-Pacific Rofecoxib Sales Quantity by Type (2019-2024) & (K Units)
Table 77. Asia-Pacific Rofecoxib Sales Quantity by Type (2025-2030) & (K Units)
Table 78. Asia-Pacific Rofecoxib Sales Quantity by Application (2019-2024) & (K Units)
Table 79. Asia-Pacific Rofecoxib Sales Quantity by Application (2025-2030) & (K Units)
Table 80. Asia-Pacific Rofecoxib Sales Quantity by Region (2019-2024) & (K Units)
Table 81. Asia-Pacific Rofecoxib Sales Quantity by Region (2025-2030) & (K Units)
Table 82. Asia-Pacific Rofecoxib Consumption Value by Region (2019-2024) & (USD Million)
Table 83. Asia-Pacific Rofecoxib Consumption Value by Region (2025-2030) & (USD Million)
Table 84. South America Rofecoxib Sales Quantity by Type (2019-2024) & (K Units)
Table 85. South America Rofecoxib Sales Quantity by Type (2025-2030) & (K Units)
Table 86. South America Rofecoxib Sales Quantity by Application (2019-2024) & (K Units)
Table 87. South America Rofecoxib Sales Quantity by Application (2025-2030) & (K Units)
Table 88. South America Rofecoxib Sales Quantity by Country (2019-2024) & (K Units)
Table 89. South America Rofecoxib Sales Quantity by Country (2025-2030) & (K Units)
Table 90. South America Rofecoxib Consumption Value by Country (2019-2024) & (USD Million)
Table 91. South America Rofecoxib Consumption Value by Country (2025-2030) & (USD Million)
Table 92. Middle East & Africa Rofecoxib Sales Quantity by Type (2019-2024) & (K Units)
Table 93. Middle East & Africa Rofecoxib Sales Quantity by Type (2025-2030) & (K Units)
Table 94. Middle East & Africa Rofecoxib Sales Quantity by Application (2019-2024) & (K Units)
Table 95. Middle East & Africa Rofecoxib Sales Quantity by Application (2025-2030) & (K Units)
Table 96. Middle East & Africa Rofecoxib Sales Quantity by Region (2019-2024) & (K Units)
Table 97. Middle East & Africa Rofecoxib Sales Quantity by Region (2025-2030) & (K Units)
Table 98. Middle East & Africa Rofecoxib Consumption Value by Region (2019-2024) & (USD Million)
Table 99. Middle East & Africa Rofecoxib Consumption Value by Region (2025-2030) & (USD Million)
Table 100. Rofecoxib Raw Material
Table 101. Key Manufacturers of Rofecoxib Raw Materials
Table 102. Rofecoxib Typical Distributors
Table 103. Rofecoxib Typical Customers
LIST OF FIGURES
Figure 1. Rofecoxib Picture
Figure 2. Global Rofecoxib Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Rofecoxib Consumption Value Market Share by Type in 2023
Figure 4. Oral Suspension. Examples
Figure 5. Tablet-Form Examples
Figure 6. Global Rofecoxib Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Rofecoxib Consumption Value Market Share by Application in 2023
Figure 8. Osteoarthritis Examples
Figure 9. Rheumatoid Arthritis Examples
Figure 10. Juvenile Rheumatoid Arthritis Examples
Figure 11. Acute Pain Conditions Examples
Figure 12. Migraine Examples
Figure 13. Dysmenorrhea Examples
Figure 14. Global Rofecoxib Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Rofecoxib Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Rofecoxib Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Rofecoxib Average Price (2019-2030) & (USD/Unit)
Figure 18. Global Rofecoxib Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Rofecoxib Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Rofecoxib by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Rofecoxib Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Rofecoxib Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Rofecoxib Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Rofecoxib Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Rofecoxib Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Rofecoxib Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Rofecoxib Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Rofecoxib Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Rofecoxib Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Rofecoxib Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Rofecoxib Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Rofecoxib Average Price by Type (2019-2030) & (USD/Unit)
Figure 33. Global Rofecoxib Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Rofecoxib Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Rofecoxib Average Price by Application (2019-2030) & (USD/Unit)
Figure 36. North America Rofecoxib Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Rofecoxib Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Rofecoxib Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Rofecoxib Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Rofecoxib Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Rofecoxib Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Rofecoxib Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Rofecoxib Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Rofecoxib Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Rofecoxib Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Rofecoxib Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Rofecoxib Consumption Value Market Share by Region (2019-2030)
Figure 56. China Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Rofecoxib Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Rofecoxib Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Rofecoxib Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Rofecoxib Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Rofecoxib Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Rofecoxib Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Rofecoxib Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Rofecoxib Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Rofecoxib Market Drivers
Figure 77. Rofecoxib Market Restraints
Figure 78. Rofecoxib Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Rofecoxib in 2023
Figure 81. Manufacturing Process Analysis of Rofecoxib
Figure 82. Rofecoxib Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Rofecoxib Picture
Figure 2. Global Rofecoxib Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Rofecoxib Consumption Value Market Share by Type in 2023
Figure 4. Oral Suspension. Examples
Figure 5. Tablet-Form Examples
Figure 6. Global Rofecoxib Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Rofecoxib Consumption Value Market Share by Application in 2023
Figure 8. Osteoarthritis Examples
Figure 9. Rheumatoid Arthritis Examples
Figure 10. Juvenile Rheumatoid Arthritis Examples
Figure 11. Acute Pain Conditions Examples
Figure 12. Migraine Examples
Figure 13. Dysmenorrhea Examples
Figure 14. Global Rofecoxib Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Rofecoxib Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Rofecoxib Sales Quantity (2019-2030) & (K Units)
Figure 17. Global Rofecoxib Average Price (2019-2030) & (USD/Unit)
Figure 18. Global Rofecoxib Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Rofecoxib Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Rofecoxib by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Rofecoxib Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Rofecoxib Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Rofecoxib Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Rofecoxib Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Rofecoxib Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Rofecoxib Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Rofecoxib Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Rofecoxib Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Rofecoxib Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Rofecoxib Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Rofecoxib Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Rofecoxib Average Price by Type (2019-2030) & (USD/Unit)
Figure 33. Global Rofecoxib Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Rofecoxib Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Rofecoxib Average Price by Application (2019-2030) & (USD/Unit)
Figure 36. North America Rofecoxib Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Rofecoxib Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Rofecoxib Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Rofecoxib Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Rofecoxib Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Rofecoxib Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Rofecoxib Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Rofecoxib Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Rofecoxib Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Rofecoxib Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Rofecoxib Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Rofecoxib Consumption Value Market Share by Region (2019-2030)
Figure 56. China Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Rofecoxib Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Rofecoxib Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Rofecoxib Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Rofecoxib Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Rofecoxib Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Rofecoxib Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Rofecoxib Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Rofecoxib Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Rofecoxib Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Rofecoxib Market Drivers
Figure 77. Rofecoxib Market Restraints
Figure 78. Rofecoxib Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Rofecoxib in 2023
Figure 81. Manufacturing Process Analysis of Rofecoxib
Figure 82. Rofecoxib Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
